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In the first nine weeks of implementation of a Zika Virus Preparedness Plan in a Mexican
Public Hospital, we cared for 221 pregnant women with any signal or symptom suggesting
Zika virus infection and 99 (44.8%) patients were found to be positive for Zika virus.
The median age of patients was 25.3 years (range 13–49). Symptoms in PCR-positive
patients were rash (91.4%) followed by headache (53.1%), myalgia (46.9%), arthralgia (45.7%),
pruritus (35.8%), retroocular pain (29.6%), conjunctivitis (21%), and fever (21%). The women’sZika virus disease
Congenital Zika virus syndrome
Microcephaly
epidemiologic exposure history indicates local transmission and a community outbreak.
©  2017 Sociedade Brasileira de Infectologia. Published by Elsevier Editora Ltda. This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/
by-nc-nd/4.0/).Zika virus (ZIKV), a vector-borne flavivirus, is responsible for
a dengue-like illness. Although many  infections are asymp-
tomatic, among those with symptoms, fever, rash, joint pain,
are characteristically observed. In 2013, a ZIKV outbreak was
reported in French Polynesia with 19,000 cases estimated.1
Two years later, local transmission of ZIKV was documented
in Brazil, with a suspected number of cases of ZIKV associated
disease of 1,300,000 by December 2015.1,2
Studies from Brazil have provided growing evidence of an
association between ZIKV infection in pregnant women and
the development of severe neural developmental disorders
3such as microcephaly in fetuses and newborns. Newborns
with microcephaly may develop hearing loss, motor skills
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problems.4
ZIKV is primarily transmitted by mosquitoes; however, sex-
ual and perinatal transmission also have been demonstrated.5
In Mexico, the first autochthonous Zika virus disease (ZVD)
case was reported in November of 2015 and occurred in a res-
ident of Monterrey.6,7
From that time and until mid-July 2016, the National
Surveillance System count remained at five ZVD cases for our
entire state, and then began a slow rise that accelerated at the
beginning of September.8
Herein we  report the first eight weeks of surveillance of
ZIKV infection among pregnant women in a third-level teach-
ing hospital in Monterrey, Mexico.
This is a teaching public hospital in Monterrey, Nuevo Leon
that serves the population of Monterrey metropolitan area and
surroundings states. The hospital has 500 beds, and on aver-
age has 22,000 hospitalization and 9000 deliveries annually.
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Fig. 1 – Distribution of Zika cases through the four weeks in the Metropolitan area of Monterrey Nuevo Leon, Mexico.
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peveral intra-institutional meetings between the laboratory
nd clinical (infectious diseases and gynecology-obstetrics)
ervices lead to a jointly developed ZVD Preparedness Plan.
The ZVD Plan details the clinical and the epidemiologic risk
ssessment to be used for any pregnant woman presenting
or care with any signal or symptom suggesting ZIKV infec-
ion (rash, headache, myalgia, arthralgia, pruritus, retroocular
ain, conjunctivitis, or/and fever) and directs the clinicians
o obtain blood and urine clinical samples for diagnostic
esting.9 The ZVD Plan was presented at our hospital-wide
rand rounds on September 13, 2016, and the surveillance of
IKV infection in pregnant women began with no reports of
ntil September 25. From Sunday evening September 25 to
eptember 26, nine pregnant and unrelated women presented
o our emergency room (ER) with any signal or symptom sug-
esting ZIKV infection. During the remainder of that week,
nd up to Saturday, November 25, an additional 212 women
resented for care to the ER with any signal or symptom sug-
esting ZIKV infection. The median age of patients was 25.33
ears (range 13–49).
In the initial 9-week period of simultaneous diagnos-
ic testing for the three arboviruses (dengue virus (DENV),
hikungunya virus (CHIKV), and ZIKV), we  processed samples
elonging to 221 patients (7 single serums, 3 single urines, and
22 paired serum and urine samples). Viral RNA was extracted
rom the serum samples by using the QIAamp Viral RNA Mini
it (QIAGEN, Hilden, Germany). RNA was reverse transcribed
y using the Superscript III Platinum OneStep Real Time RT-
CR system (Invitrogen, Carlsbad, CA, USA) and subjected to
CRs specific for DENV, CHIKV, and ZIKV using the CDC Trio-
lex Real-time RT-PCR Assay.10
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patient was positive for CHIKV (and not for DENV or ZIKV);
three patients were positive for DENV (and not for CHIKV or
ZIKV) and 99 (44.8%) patients were positive for ZIKV. Symp-
toms in PCR-positive patients were rash (91.4%) followed by
headache (53.1%), myalgia (46.9%), arthralgia (45.7%), pruri-
tus (35.8%), retroocular pain (29.6%), conjunctivitis (21%), fever
(21%), and diarrhea (2.5%). The gestational ages of the 221
pregnancies ranged from 4.5 to 41.5 weeks (8.3% in the first
and 20.4% in the second trimester). All had a high-resolution
ultrasonographic (HRUS) evaluation and no cranial abnormali-
ties or other abnormal findings in the fetuses, or the placentas
were detected in this baseline assessment. Two women with
conditions deemed to be unrelated to ZVD (one at risk of
preterm labor, one with a UTI) were hospitalized and resolved
satisfactorily; all others were discharged home from the diag-
nostic ER visit.
All the women are residents of the Monterrey metropoli-
tan area (Fig. 1). None reported a travel history consistent
with ZIKV transmission occurring somewhere besides their
place of residency. Seventy RT-PCR positive patients provided
information about local exposure: 37 (52.9%) had community
contacts with similar febrile rash illness, 18 (25.7%) had both
community and intradomiciliary ill contacts, and 4 (5.7%) had
in-house contacts. Among the 118 RT-PCR-negative patients
with probable ZVD, the most common symptom was rash
(81.3%), and 78.4% reported community ill contacts.We composed the ZVD Plan expecting to activate it grad-
ually; but instead, we  quickly faced an epidemic. Our ZVD
Preparedness Plan further includes (a) monthly obstetric HRUS
for possible congenital findings, (b) ZIKV RNA testing of babies
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and mothers, and (c) monitoring the children by the neu-
ropediatric specialists. To date, six women have delivered a
healthy live infant, with no evidence of neurological damage
in newborns. Maternal and infant blood and urines all tested
PCR-negative for ZIKV.
Our health facility is a teaching hospital in Monterrey,
Nuevo Leon State, Mexico. Nuevo Leon is northern landlocked
Mexico State, and our environmental conditions permit the
existence of the Aedes vector that transmits Dengue, Chikun-
gunya and Zika. The unpredicted swiftness of ZIKV spread that
caused our Action Plan to be put into implementation mode at
top speed, to respond to what appears to be a very large out-
break occurring which is still occurring in our city and among
the population that uses our hospital for their primary health
care needs, including prenatal and obstetric care. We want to
document the lessons learned and challenges faced and share
them with other institutions facing the same problem.
This report describes the rapid spread of an ongoing out-
break of ZVD affecting the pregnant women cared for at our
hospital, and the involvedness of managing an institutional
response to a health crisis.
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